The Comparative Safety of Abciximab Versus Eptifibatide in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to evaluate the patterns of use and outcomes associated with eptifibatide and abciximab administration among dialysis patients who underwent PCI. BACKGROUND: Contraindicated medications are frequently administered to dialysis patients undergoing PCI often resulting in adverse o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Interv Cardiol
Autores principales: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Hanzel, George, Khandelwal, Akshay, Cannon, Louis A., Lalonde, Thomas A., Gurm, Hitinder S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850214/
https://ncbi.nlm.nih.gov/pubmed/28543770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joic.12388
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares